# US 2024/0197174 A1 · Ocular health index determination and usage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197174 A1
- Document ID: US20240197174A1
- Status: Published application
- Kind: A1
- Application number: 18/287,275
- Filed: 2022-04-27
- Published: 2024-06-20
- Earliest claimed: 2021-04-28
- Assignees: Balance Ophthalmics, Inc.
- Applicants: Balance Ophthalmics, Inc.
- Inventors: John Berdahl; Gary Berman; Enrico Brambilla
- Web page: https://patentgrep.com/patent/US20240197174A1

## CPC

- A61B 3/16: for measuring intraocular pressure, e.g. tonometers
- A61F 9/0008: {Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00)}
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61F 9/029: {Additional functions or features, e.g. protection for other parts of the face such as ears, nose or mouth; Screen wipers or cleaning devices}
- G16H 20/17: delivered via infusion or injection
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 40/63: for local operation
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/6803: {Head-worn items, e.g. helmets, masks, headphones or goggles}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Eye health of a patient can be monitored and various ocular conditions treated such as using information about an intraocular pressure (IOP) characteristic of the patient, information about a blood pressure (BP) characteristic of the patient, and information about a patient therapy, such as from a patient treatment system. In an example, a quantitative ocular health index can be determined for a patient based on information about an IOP characteristic, a BP characteristic, and the patient therapy.

## Claims

### Claim at position 1

1-67. (canceled)

### Claim 68

A patient treatment system to determine an ocular health index (OHI) value for a patient eye, the patient treatment system comprising:
a processor circuit, in communication with a pump, the processor circuit configured to:
receive a first indication of intraocular pressure (IOP) in the patient eye over a first time interval and a first indication of blood pressure (BP) from the patient over the first time interval; and
generate the OHI value based at least in part on the first indication of IOP and the first indication of BP.

### Claim 69 (depends on 68)

The patient treatment system of claim 68, wherein the processor circuit is configured to determine an indication of glaucoma disease progression based on the OHI value.

### Claim 70 (depends on 68)

The patient treatment system of claim 68, wherein the OHI value is an indication of ocular perfusion pressure (OPP).

### Claim 71 (depends on 69)

The patient treatment system of claim 69, wherein the processor circuit is configured to:
receive the first indication of intraocular pressure (IOP) in the patient eye over the first time interval and the first indication of a blood pressure (BP) from the patient over the first time interval, wherein the first time interval occurs prior to applying a therapy to the patient eye;
receive a second indication of IOP in the patient eye over a second time interval and a second indication of BP from the patient over the second time interval, wherein the second time interval occurs after applying the therapy to the patient eye;
determine an IOP difference between the received first and second indications of IOP;
determine a BP difference between the received first and second indications of BP; and
generate the OHI value based at least in part on the determined IOP difference and the determined BP difference to determine an effect of the therapy on the patient eye.

### Claim 72 (depends on 71)

The patient treatment system of claim 71, wherein the processor circuit is configured to determine the OHI value based at least in part on information about the therapy provided to the patient.

### Claim 73 (depends on 71)

The patient treatment system of claim 71, wherein the therapy applied to the patient eye includes at least one of a goggle-based therapy or a drug delivery therapy.

### Claim 74 (depends on 73)

The patient treatment system of claim 73, wherein the therapy applied to the patient eye is the goggle-based therapy.

### Claim 75 (depends on 74)

The patient treatment system of claim 74, wherein the processor circuit is configured to determine the OHI value based at least in part on information about the goggle-based therapy provided to the patient.

### Claim 76 (depends on 73)

The patient treatment system of claim 73, wherein the therapy applied to the patient eye is the drug delivery therapy.

### Claim 77 (depends on 68)

The patient treatment system of claim 68, further comprising a patient interface configured to identify a field of vision of the patient wherein the patient interface includes at least one of a virtual reality (VR) headset or other head-mounted system.

### Claim 78 (depends on 68)

The patient treatment system of claim 68, further comprising:
a goggle, configured to fit over the patient eye to form a cavity over the patient eye; and
a pump, in communication with the cavity, configured to affect establish a fluid pressure in the cavity.

### Claim 79

A method of using a patient treatment system to determine an ocular health index (OHI) value for a patient eye, the method comprising:
receiving with a processor circuit a first indication of intraocular pressure (IOP) in the patient eye over a first time interval and a first indication of blood pressure (BP) from the patient over the first time interval; and
generating the OHI value based at least in part on the first indication of IOP and the first indication of BP.

### Claim 80 (depends on 79)

The method of claim 79, wherein generating the OHI value includes generating an indication of glaucoma disease progression based on the OHI value.

### Claim 81 (depends on 79)

The method of claim 79, wherein generating the OHI value includes generating an indication of ocular perfusion pressure (OPP).

### Claim 82 (depends on 79)

The method of claim 79, wherein,
receiving with a processor circuit includes receiving the first indication of intraocular pressure (IOP) in the patient eye over the first time interval and the first indication of a blood pressure (BP) from the patient over the first time interval, wherein the first time interval occurs prior to applying a therapy to the patient eye; and,
the method further comprising:
receiving a second indication of IOP in the patient eye over a second time interval and a second indication of BP from the patient over the second time interval, wherein the second time interval occurs after applying the therapy to the patient eye;
determining an IOP difference between the received first and second indications of IOP;
determining a BP difference between the received first and second indications of BP, and
generating the OHI value based at least in part on the determined IOP difference and the determined BP difference to determine an effect of the therapy on the patient eye.

### Claim 83 (depends on 82)

The method of claim 82, wherein generating the OHI value includes generating the OHI value based at least in part on information about the therapy provided to the patient.

### Claim 84 (depends on 82)

The method of claim 82, wherein generating the OHI value includes generating the OHI value with a therapy applied to the patient eye, the therapy including at least one of a goggle-based therapy or a drug delivery therapy.

### Claim 85 (depends on 84)

The method of claim 84 wherein generating the OHI value includes generating the OHI value with the goggle-based therapy.

### Claim 86 (depends on 84)

The method of claim 84 wherein generating the OHI value includes generating the OHI value with the drug delivery therapy.

### Claim 87 (depends on 79)

The method of claim 79 further comprising receiving information from a patient interface configured to identify a field of vision of the patient to determine or update the OHI value.
